Tropical Disease Voucher Program Would See Another Boost In Cures Bill
Executive Summary
FDA would gain ability to easily change list of diseases eligible for incentive, avoiding need for one-off legislation or rulemaking.
You may also be interested in...
Drug Shortages: Would Sponsors Admit Their Products Are Vulnerable?
US FDA's upcoming drug shortage risk criteria will be made public and sponsors could be asked to find the vulnerable products in their portfolios.
Drug Shortages: Would Sponsors Admit Their Products Are Vulnerable?
US FDA's upcoming drug shortage risk criteria will be made public and sponsors could be asked to find the vulnerable products in their portfolios.
Neglected Tropical Disease Designation Rejected For First Time By US FDA
Pneumocystis pneumonia was determined to not meet criteria for a neglected tropical disease that could win sponsors of a new treatment a priority review voucher; FDA made four other diseases eligible.